Diagnosis (NIRS) and treatment (BVS) of vulnerable plaque: PROSPECT II - Gregg W. Stone, MD

↳ This is a section part of Moment: CRT 2015 Atherosclerosis & Research - Vulnerable Plaque Clinical Trials

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Diagnosis (NIRS) and treatment (BVS) of vulnerable plaque: PROSPECT II presented by Gregg W. Stone, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physiology technicians
  • Nurses and other allied healthcare professionals 
  • Imaging Specialists
  • Radiologists

Session Name: Vulnerable Plaque Clinical Trials

Track: Atherosclerosis & Research

Learning Objectives

  • The latest updates in Atherosclerosis & Research

Other Components in this Moment

Overview
Near Infrared Spectroscopy (NIRS): LRP Study Update - Ron Waksman, MD
Diagnosis (NIRS) and treatment (BVS) of vulnerable plaque: PROSPECT II - Gregg W. Stone, MD
Can NIRS Detect Vulnerable Plaque? The Rotterdam Experience - P. Serruys, MD, PhD
Precision Phenotyping, Panomics to Delineate Complex Biologies of Atherosclerosis - Szilard Voros, MD
COLOR Registry: Lessons Learned - Akiko Maehara, MD
Loading Simple Education